Global Biopharmaceutical Buffers Market Research Report 2024

SKU ID :QYR-26781796 | Published Date: 05-Feb-2024 | No. of pages: 87
1 Biopharmaceutical Buffers Market Overview 1.1 Product Overview and Scope of Biopharmaceutical Buffers 1.2 Biopharmaceutical Buffers Segment by Type 1.2.1 Global Biopharmaceutical Buffers Market Value Comparison by Type (2024-2030) 1.2.2 Sterile Buffer 1.2.3 Non-sterile Buffer 1.3 Biopharmaceutical Buffers Segment by Application 1.3.1 Global Biopharmaceutical Buffers Market Value by Application: (2024-2030) 1.3.2 Recombinant Proteins 1.3.3 Monoclonal Antibodies 1.3.4 Antibiotics 1.3.5 Probiotics 1.3.6 Other 1.4 Global Biopharmaceutical Buffers Market Size Estimates and Forecasts 1.4.1 Global Biopharmaceutical Buffers Revenue 2019-2030 1.4.2 Global Biopharmaceutical Buffers Sales 2019-2030 1.4.3 Global Biopharmaceutical Buffers Market Average Price (2019-2030) 1.5 Assumptions and Limitations 2 Biopharmaceutical Buffers Market Competition by Manufacturers 2.1 Global Biopharmaceutical Buffers Sales Market Share by Manufacturers (2019-2024) 2.2 Global Biopharmaceutical Buffers Revenue Market Share by Manufacturers (2019-2024) 2.3 Global Biopharmaceutical Buffers Average Price by Manufacturers (2019-2024) 2.4 Global Biopharmaceutical Buffers Industry Ranking 2022 VS 2023 VS 2024 2.5 Global Key Manufacturers of Biopharmaceutical Buffers, Manufacturing Sites & Headquarters 2.6 Global Key Manufacturers of Biopharmaceutical Buffers, Product Type & Application 2.7 Biopharmaceutical Buffers Market Competitive Situation and Trends 2.7.1 Biopharmaceutical Buffers Market Concentration Rate 2.7.2 The Global Top 5 and Top 10 Largest Biopharmaceutical Buffers Players Market Share by Revenue 2.7.3 Global Biopharmaceutical Buffers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.8 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Biopharmaceutical Buffers Retrospective Market Scenario by Region 3.1 Global Biopharmaceutical Buffers Market Size by Region: 2019 Versus 2023 Versus 2030 3.2 Global Biopharmaceutical Buffers Global Biopharmaceutical Buffers Sales by Region: 2019-2030 3.2.1 Global Biopharmaceutical Buffers Sales by Region: 2019-2024 3.2.2 Global Biopharmaceutical Buffers Sales by Region: 2025-2030 3.3 Global Biopharmaceutical Buffers Global Biopharmaceutical Buffers Revenue by Region: 2019-2030 3.3.1 Global Biopharmaceutical Buffers Revenue by Region: 2019-2024 3.3.2 Global Biopharmaceutical Buffers Revenue by Region: 2025-2030 3.4 North America Biopharmaceutical Buffers Market Facts & Figures by Country 3.4.1 North America Biopharmaceutical Buffers Market Size by Country: 2019 VS 2023 VS 2030 3.4.2 North America Biopharmaceutical Buffers Sales by Country (2019-2030) 3.4.3 North America Biopharmaceutical Buffers Revenue by Country (2019-2030) 3.4.4 U.S. 3.4.5 Canada 3.5 Europe Biopharmaceutical Buffers Market Facts & Figures by Country 3.5.1 Europe Biopharmaceutical Buffers Market Size by Country: 2019 VS 2023 VS 2030 3.5.2 Europe Biopharmaceutical Buffers Sales by Country (2019-2030) 3.5.3 Europe Biopharmaceutical Buffers Revenue by Country (2019-2030) 3.5.4 Germany 3.5.5 France 3.5.6 U.K. 3.5.7 Italy 3.5.8 Russia 3.6 Asia Pacific Biopharmaceutical Buffers Market Facts & Figures by Country 3.6.1 Asia Pacific Biopharmaceutical Buffers Market Size by Country: 2019 VS 2023 VS 2030 3.6.2 Asia Pacific Biopharmaceutical Buffers Sales by Country (2019-2030) 3.6.3 Asia Pacific Biopharmaceutical Buffers Revenue by Country (2019-2030) 3.6.4 China 3.6.5 Japan 3.6.6 South Korea 3.6.7 India 3.6.8 Australia 3.6.9 Taiwan 3.6.10 Indonesia 3.6.11 Thailand 3.6.12 Malaysia 3.6.13 Philippines 3.7 Latin America Biopharmaceutical Buffers Market Facts & Figures by Country 3.7.1 Latin America Biopharmaceutical Buffers Market Size by Country: 2019 VS 2023 VS 2030 3.7.2 Latin America Biopharmaceutical Buffers Sales by Country (2019-2030) 3.7.3 Latin America Biopharmaceutical Buffers Revenue by Country (2019-2030) 3.7.4 Mexico 3.7.5 Brazil 3.7.6 Argentina 3.8 Middle East and Africa Biopharmaceutical Buffers Market Facts & Figures by Country 3.8.1 Middle East and Africa Biopharmaceutical Buffers Market Size by Country: 2019 VS 2023 VS 2030 3.8.2 Middle East and Africa Biopharmaceutical Buffers Sales by Country (2019-2030) 3.8.3 Middle East and Africa Biopharmaceutical Buffers Revenue by Country (2019-2030) 3.8.4 Turkey 3.8.5 Saudi Arabia 3.8.6 U.A.E 4 Segment by Type 4.1 Global Biopharmaceutical Buffers Sales by Type (2019-2030) 4.1.1 Global Biopharmaceutical Buffers Sales by Type (2019-2024) 4.1.2 Global Biopharmaceutical Buffers Sales by Type (2025-2030) 4.1.3 Global Biopharmaceutical Buffers Sales Market Share by Type (2019-2030) 4.2 Global Biopharmaceutical Buffers Revenue by Type (2019-2030) 4.2.1 Global Biopharmaceutical Buffers Revenue by Type (2019-2024) 4.2.2 Global Biopharmaceutical Buffers Revenue by Type (2025-2030) 4.2.3 Global Biopharmaceutical Buffers Revenue Market Share by Type (2019-2030) 4.3 Global Biopharmaceutical Buffers Price by Type (2019-2030) 5 Segment by Application 5.1 Global Biopharmaceutical Buffers Sales by Application (2019-2030) 5.1.1 Global Biopharmaceutical Buffers Sales by Application (2019-2024) 5.1.2 Global Biopharmaceutical Buffers Sales by Application (2025-2030) 5.1.3 Global Biopharmaceutical Buffers Sales Market Share by Application (2019-2030) 5.2 Global Biopharmaceutical Buffers Revenue by Application (2019-2030) 5.2.1 Global Biopharmaceutical Buffers Revenue by Application (2019-2024) 5.2.2 Global Biopharmaceutical Buffers Revenue by Application (2025-2030) 5.2.3 Global Biopharmaceutical Buffers Revenue Market Share by Application (2019-2030) 5.3 Global Biopharmaceutical Buffers Price by Application (2019-2030) 6 Key Companies Profiled 6.1 GE Healthcare 6.1.1 GE Healthcare Corporation Information 6.1.2 GE Healthcare Description and Business Overview 6.1.3 GE Healthcare Biopharmaceutical Buffers Sales, Revenue and Gross Margin (2019-2024) 6.1.4 GE Healthcare Biopharmaceutical Buffers Product Portfolio 6.1.5 GE Healthcare Recent Developments/Updates 6.2 Thermo Fisher Scientific 6.2.1 Thermo Fisher Scientific Corporation Information 6.2.2 Thermo Fisher Scientific Description and Business Overview 6.2.3 Thermo Fisher Scientific Biopharmaceutical Buffers Sales, Revenue and Gross Margin (2019-2024) 6.2.4 Thermo Fisher Scientific Biopharmaceutical Buffers Product Portfolio 6.2.5 Thermo Fisher Scientific Recent Developments/Updates 6.3 Danaher Corporation 6.3.1 Danaher Corporation Corporation Information 6.3.2 Danaher Corporation Description and Business Overview 6.3.3 Danaher Corporation Biopharmaceutical Buffers Sales, Revenue and Gross Margin (2019-2024) 6.3.4 Danaher Corporation Biopharmaceutical Buffers Product Portfolio 6.3.5 Danaher Corporation Recent Developments/Updates 6.4 Sartorius StedimBiotech 6.4.1 Sartorius StedimBiotech Corporation Information 6.4.2 Sartorius StedimBiotech Description and Business Overview 6.4.3 Sartorius StedimBiotech Biopharmaceutical Buffers Sales, Revenue and Gross Margin (2019-2024) 6.4.4 Sartorius StedimBiotech Biopharmaceutical Buffers Product Portfolio 6.4.5 Sartorius StedimBiotech Recent Developments/Updates 6.5 Merck 6.5.1 Merck Corporation Information 6.5.2 Merck Description and Business Overview 6.5.3 Merck Biopharmaceutical Buffers Sales, Revenue and Gross Margin (2019-2024) 6.5.4 Merck Biopharmaceutical Buffers Product Portfolio 6.5.5 Merck Recent Developments/Updates 6.6 Eppendorf 6.6.1 Eppendorf Corporation Information 6.6.2 Eppendorf Description and Business Overview 6.6.3 Eppendorf Biopharmaceutical Buffers Sales, Revenue and Gross Margin (2019-2024) 6.6.4 Eppendorf Biopharmaceutical Buffers Product Portfolio 6.6.5 Eppendorf Recent Developments/Updates 6.7 Roche 6.6.1 Roche Corporation Information 6.6.2 Roche Description and Business Overview 6.6.3 Roche Biopharmaceutical Buffers Sales, Revenue and Gross Margin (2019-2024) 6.4.4 Roche Biopharmaceutical Buffers Product Portfolio 6.7.5 Roche Recent Developments/Updates 6.8 Nova Biomedicals 6.8.1 Nova Biomedicals Corporation Information 6.8.2 Nova Biomedicals Description and Business Overview 6.8.3 Nova Biomedicals Biopharmaceutical Buffers Sales, Revenue and Gross Margin (2019-2024) 6.8.4 Nova Biomedicals Biopharmaceutical Buffers Product Portfolio 6.8.5 Nova Biomedicals Recent Developments/Updates 6.9 Lonza 6.9.1 Lonza Corporation Information 6.9.2 Lonza Description and Business Overview 6.9.3 Lonza Biopharmaceutical Buffers Sales, Revenue and Gross Margin (2019-2024) 6.9.4 Lonza Biopharmaceutical Buffers Product Portfolio 6.9.5 Lonza Recent Developments/Updates 6.10 Becton, and Dickinson and Company 6.10.1 Becton, and Dickinson and Company Corporation Information 6.10.2 Becton, and Dickinson and Company Description and Business Overview 6.10.3 Becton, and Dickinson and Company Biopharmaceutical Buffers Sales, Revenue and Gross Margin (2019-2024) 6.10.4 Becton, and Dickinson and Company Biopharmaceutical Buffers Product Portfolio 6.10.5 Becton, and Dickinson and Company Recent Developments/Updates 6.11 GEA 6.11.1 GEA Corporation Information 6.11.2 GEA Biopharmaceutical Buffers Description and Business Overview 6.11.3 GEA Biopharmaceutical Buffers Sales, Revenue and Gross Margin (2019-2024) 6.11.4 GEA Biopharmaceutical Buffers Product Portfolio 6.11.5 GEA Recent Developments/Updates 7 Industry Chain and Sales Channels Analysis 7.1 Biopharmaceutical Buffers Industry Chain Analysis 7.2 Biopharmaceutical Buffers Key Raw Materials 7.2.1 Key Raw Materials 7.2.2 Raw Materials Key Suppliers 7.3 Biopharmaceutical Buffers Production Mode & Process 7.4 Biopharmaceutical Buffers Sales and Marketing 7.4.1 Biopharmaceutical Buffers Sales Channels 7.4.2 Biopharmaceutical Buffers Distributors 7.5 Biopharmaceutical Buffers Customers 8 Biopharmaceutical Buffers Market Dynamics 8.1 Biopharmaceutical Buffers Industry Trends 8.2 Biopharmaceutical Buffers Market Drivers 8.3 Biopharmaceutical Buffers Market Challenges 8.4 Biopharmaceutical Buffers Market Restraints 9 Research Finding and Conclusion 10 Methodology and Data Source 10.1 Methodology/Research Approach 10.1.1 Research Programs/Design 10.1.2 Market Size Estimation 10.1.3 Market Breakdown and Data Triangulation 10.2 Data Source 10.2.1 Secondary Sources 10.2.2 Primary Sources 10.3 Author List 10.4 Disclaimer
List of Tables Table 1. Global Biopharmaceutical Buffers Market Value Comparison by Type (2024-2030) & (US$ Million) Table 2. Global Biopharmaceutical Buffers Market Value Comparison by Application (2024-2030) & (US$ Million) Table 3. Global Biopharmaceutical Buffers Market Competitive Situation by Manufacturers in 2023 Table 4. Global Biopharmaceutical Buffers Sales (K MT) of Key Manufacturers (2019-2024) Table 5. Global Biopharmaceutical Buffers Sales Market Share by Manufacturers (2019-2024) Table 6. Global Biopharmaceutical Buffers Revenue (US$ Million) by Manufacturers (2019-2024) Table 7. Global Biopharmaceutical Buffers Revenue Share by Manufacturers (2019-2024) Table 8. Global Market Biopharmaceutical Buffers Average Price (USD/MT) of Key Manufacturers (2019-2024) Table 9. Global Key Players of Biopharmaceutical Buffers, Industry Ranking, 2022 VS 2023 VS 2024 Table 10. Global Key Manufacturers of Biopharmaceutical Buffers, Manufacturing Sites & Headquarters Table 11. Global Key Manufacturers of Biopharmaceutical Buffers, Product Type & Application Table 12. Global Key Manufacturers of Biopharmaceutical Buffers, Date of Enter into This Industry Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 14. Global Biopharmaceutical Buffers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharmaceutical Buffers as of 2023) Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans Table 16. Global Biopharmaceutical Buffers Market Size by Region (US$ Million): 2019 VS 2023 VS 2030 Table 17. Global Biopharmaceutical Buffers Sales by Region (2019-2024) & (K MT) Table 18. Global Biopharmaceutical Buffers Sales Market Share by Region (2019-2024) Table 19. Global Biopharmaceutical Buffers Sales by Region (2025-2030) & (K MT) Table 20. Global Biopharmaceutical Buffers Sales Market Share by Region (2025-2030) Table 21. Global Biopharmaceutical Buffers Revenue by Region (2019-2024) & (US$ Million) Table 22. Global Biopharmaceutical Buffers Revenue Market Share by Region (2019-2024) Table 23. Global Biopharmaceutical Buffers Revenue by Region (2025-2030) & (US$ Million) Table 24. Global Biopharmaceutical Buffers Revenue Market Share by Region (2025-2030) Table 25. North America Biopharmaceutical Buffers Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million) Table 26. North America Biopharmaceutical Buffers Sales by Country (2019-2024) & (K MT) Table 27. North America Biopharmaceutical Buffers Sales by Country (2025-2030) & (K MT) Table 28. North America Biopharmaceutical Buffers Revenue by Country (2019-2024) & (US$ Million) Table 29. North America Biopharmaceutical Buffers Revenue by Country (2025-2030) & (US$ Million) Table 30. Europe Biopharmaceutical Buffers Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million) Table 31. Europe Biopharmaceutical Buffers Sales by Country (2019-2024) & (K MT) Table 32. Europe Biopharmaceutical Buffers Sales by Country (2025-2030) & (K MT) Table 33. Europe Biopharmaceutical Buffers Revenue by Country (2019-2024) & (US$ Million) Table 34. Europe Biopharmaceutical Buffers Revenue by Country (2025-2030) & (US$ Million) Table 35. Asia Pacific Biopharmaceutical Buffers Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million) Table 36. Asia Pacific Biopharmaceutical Buffers Sales by Region (2019-2024) & (K MT) Table 37. Asia Pacific Biopharmaceutical Buffers Sales by Region (2025-2030) & (K MT) Table 38. Asia Pacific Biopharmaceutical Buffers Revenue by Region (2019-2024) & (US$ Million) Table 39. Asia Pacific Biopharmaceutical Buffers Revenue by Region (2025-2030) & (US$ Million) Table 40. Latin America Biopharmaceutical Buffers Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million) Table 41. Latin America Biopharmaceutical Buffers Sales by Country (2019-2024) & (K MT) Table 42. Latin America Biopharmaceutical Buffers Sales by Country (2025-2030) & (K MT) Table 43. Latin America Biopharmaceutical Buffers Revenue by Country (2019-2024) & (US$ Million) Table 44. Latin America Biopharmaceutical Buffers Revenue by Country (2025-2030) & (US$ Million) Table 45. Middle East & Africa Biopharmaceutical Buffers Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million) Table 46. Middle East & Africa Biopharmaceutical Buffers Sales by Country (2019-2024) & (K MT) Table 47. Middle East & Africa Biopharmaceutical Buffers Sales by Country (2025-2030) & (K MT) Table 48. Middle East & Africa Biopharmaceutical Buffers Revenue by Country (2019-2024) & (US$ Million) Table 49. Middle East & Africa Biopharmaceutical Buffers Revenue by Country (2025-2030) & (US$ Million) Table 50. Global Biopharmaceutical Buffers Sales (K MT) by Type (2019-2024) Table 51. Global Biopharmaceutical Buffers Sales (K MT) by Type (2025-2030) Table 52. Global Biopharmaceutical Buffers Sales Market Share by Type (2019-2024) Table 53. Global Biopharmaceutical Buffers Sales Market Share by Type (2025-2030) Table 54. Global Biopharmaceutical Buffers Revenue (US$ Million) by Type (2019-2024) Table 55. Global Biopharmaceutical Buffers Revenue (US$ Million) by Type (2025-2030) Table 56. Global Biopharmaceutical Buffers Revenue Market Share by Type (2019-2024) Table 57. Global Biopharmaceutical Buffers Revenue Market Share by Type (2025-2030) Table 58. Global Biopharmaceutical Buffers Price (USD/MT) by Type (2019-2024) Table 59. Global Biopharmaceutical Buffers Price (USD/MT) by Type (2025-2030) Table 60. Global Biopharmaceutical Buffers Sales (K MT) by Application (2019-2024) Table 61. Global Biopharmaceutical Buffers Sales (K MT) by Application (2025-2030) Table 62. Global Biopharmaceutical Buffers Sales Market Share by Application (2019-2024) Table 63. Global Biopharmaceutical Buffers Sales Market Share by Application (2025-2030) Table 64. Global Biopharmaceutical Buffers Revenue (US$ Million) by Application (2019-2024) Table 65. Global Biopharmaceutical Buffers Revenue (US$ Million) by Application (2025-2030) Table 66. Global Biopharmaceutical Buffers Revenue Market Share by Application (2019-2024) Table 67. Global Biopharmaceutical Buffers Revenue Market Share by Application (2025-2030) Table 68. Global Biopharmaceutical Buffers Price (USD/MT) by Application (2019-2024) Table 69. Global Biopharmaceutical Buffers Price (USD/MT) by Application (2025-2030) Table 70. GE Healthcare Corporation Information Table 71. GE Healthcare Description and Business Overview Table 72. GE Healthcare Biopharmaceutical Buffers Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024) Table 73. GE Healthcare Biopharmaceutical Buffers Product Table 74. GE Healthcare Recent Developments/Updates Table 75. Thermo Fisher Scientific Corporation Information Table 76. Thermo Fisher Scientific Description and Business Overview Table 77. Thermo Fisher Scientific Biopharmaceutical Buffers Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024) Table 78. Thermo Fisher Scientific Biopharmaceutical Buffers Product Table 79. Thermo Fisher Scientific Recent Developments/Updates Table 80. Danaher Corporation Corporation Information Table 81. Danaher Corporation Description and Business Overview Table 82. Danaher Corporation Biopharmaceutical Buffers Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024) Table 83. Danaher Corporation Biopharmaceutical Buffers Product Table 84. Danaher Corporation Recent Developments/Updates Table 85. Sartorius StedimBiotech Corporation Information Table 86. Sartorius StedimBiotech Description and Business Overview Table 87. Sartorius StedimBiotech Biopharmaceutical Buffers Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024) Table 88. Sartorius StedimBiotech Biopharmaceutical Buffers Product Table 89. Sartorius StedimBiotech Recent Developments/Updates Table 90. Merck Corporation Information Table 91. Merck Description and Business Overview Table 92. Merck Biopharmaceutical Buffers Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024) Table 93. Merck Biopharmaceutical Buffers Product Table 94. Merck Recent Developments/Updates Table 95. Eppendorf Corporation Information Table 96. Eppendorf Description and Business Overview Table 97. Eppendorf Biopharmaceutical Buffers Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024) Table 98. Eppendorf Biopharmaceutical Buffers Product Table 99. Eppendorf Recent Developments/Updates Table 100. Roche Corporation Information Table 101. Roche Description and Business Overview Table 102. Roche Biopharmaceutical Buffers Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024) Table 103. Roche Biopharmaceutical Buffers Product Table 104. Roche Recent Developments/Updates Table 105. Nova Biomedicals Corporation Information Table 106. Nova Biomedicals Description and Business Overview Table 107. Nova Biomedicals Biopharmaceutical Buffers Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024) Table 108. Nova Biomedicals Biopharmaceutical Buffers Product Table 109. Nova Biomedicals Recent Developments/Updates Table 110. Lonza Corporation Information Table 111. Lonza Description and Business Overview Table 112. Lonza Biopharmaceutical Buffers Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024) Table 113. Lonza Biopharmaceutical Buffers Product Table 114. Lonza Recent Developments/Updates Table 115. Becton, and Dickinson and Company Corporation Information Table 116. Becton, and Dickinson and Company Description and Business Overview Table 117. Becton, and Dickinson and Company Biopharmaceutical Buffers Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024) Table 118. Becton, and Dickinson and Company Biopharmaceutical Buffers Product Table 119. Becton, and Dickinson and Company Recent Developments/Updates Table 120. GEA Corporation Information Table 121. GEA Description and Business Overview Table 122. GEA Biopharmaceutical Buffers Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024) Table 123. GEA Biopharmaceutical Buffers Product Table 124. GEA Recent Developments/Updates Table 125. Key Raw Materials Lists Table 126. Raw Materials Key Suppliers Lists Table 127. Biopharmaceutical Buffers Distributors List Table 128. Biopharmaceutical Buffers Customers List Table 129. Biopharmaceutical Buffers Market Trends Table 130. Biopharmaceutical Buffers Market Drivers Table 131. Biopharmaceutical Buffers Market Challenges Table 132. Biopharmaceutical Buffers Market Restraints Table 133. Research Programs/Design for This Report Table 134. Key Data Information from Secondary Sources Table 135. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Biopharmaceutical Buffers Figure 2. Global Biopharmaceutical Buffers Market Value Comparison by Type (2024-2030) & (US$ Million) Figure 3. Global Biopharmaceutical Buffers Market Share by Type in 2023 & 2030 Figure 4. Sterile Buffer Product Picture Figure 5. Non-sterile Buffer Product Picture Figure 6. Global Biopharmaceutical Buffers Market Value Comparison by Application (2024-2030) & (US$ Million) Figure 7. Global Biopharmaceutical Buffers Market Share by Application in 2023 & 2030 Figure 8. Recombinant Proteins Figure 9. Monoclonal Antibodies Figure 10. Antibiotics Figure 11. Probiotics Figure 12. Other Figure 13. Global Biopharmaceutical Buffers Revenue, (US$ Million), 2019 VS 2023 VS 2030 Figure 14. Global Biopharmaceutical Buffers Market Size (2019-2030) & (US$ Million) Figure 15. Global Biopharmaceutical Buffers Sales (2019-2030) & (K MT) Figure 16. Global Biopharmaceutical Buffers Average Price (USD/MT) & (2019-2030) Figure 17. Biopharmaceutical Buffers Report Years Considered Figure 18. Biopharmaceutical Buffers Sales Share by Manufacturers in 2023 Figure 19. Global Biopharmaceutical Buffers Revenue Share by Manufacturers in 2023 Figure 20. The Global 5 and 10 Largest Biopharmaceutical Buffers Players: Market Share by Revenue in 2023 Figure 21. Biopharmaceutical Buffers Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023 Figure 22. Global Biopharmaceutical Buffers Market Size by Region (US$ Million): 2019 VS 2023 VS 2030 Figure 23. North America Biopharmaceutical Buffers Sales Market Share by Country (2019-2030) Figure 24. North America Biopharmaceutical Buffers Revenue Market Share by Country (2019-2030) Figure 25. U.S. Biopharmaceutical Buffers Revenue Growth Rate (2019-2030) & (US$ Million) Figure 26. Canada Biopharmaceutical Buffers Revenue Growth Rate (2019-2030) & (US$ Million) Figure 27. Europe Biopharmaceutical Buffers Sales Market Share by Country (2019-2030) Figure 28. Europe Biopharmaceutical Buffers Revenue Market Share by Country (2019-2030) Figure 29. Germany Biopharmaceutical Buffers Revenue Growth Rate (2019-2030) & (US$ Million) Figure 30. France Biopharmaceutical Buffers Revenue Growth Rate (2019-2030) & (US$ Million) Figure 31. U.K. Biopharmaceutical Buffers Revenue Growth Rate (2019-2030) & (US$ Million) Figure 32. Italy Biopharmaceutical Buffers Revenue Growth Rate (2019-2030) & (US$ Million) Figure 33. Russia Biopharmaceutical Buffers Revenue Growth Rate (2019-2030) & (US$ Million) Figure 34. Asia Pacific Biopharmaceutical Buffers Sales Market Share by Region (2019-2030) Figure 35. Asia Pacific Biopharmaceutical Buffers Revenue Market Share by Region (2019-2030) Figure 36. China Biopharmaceutical Buffers Revenue Growth Rate (2019-2030) & (US$ Million) Figure 37. Japan Biopharmaceutical Buffers Revenue Growth Rate (2019-2030) & (US$ Million) Figure 38. South Korea Biopharmaceutical Buffers Revenue Growth Rate (2019-2030) & (US$ Million) Figure 39. India Biopharmaceutical Buffers Revenue Growth Rate (2019-2030) & (US$ Million) Figure 40. Australia Biopharmaceutical Buffers Revenue Growth Rate (2019-2030) & (US$ Million) Figure 41. Taiwan Biopharmaceutical Buffers Revenue Growth Rate (2019-2030) & (US$ Million) Figure 42. Indonesia Biopharmaceutical Buffers Revenue Growth Rate (2019-2030) & (US$ Million) Figure 43. Thailand Biopharmaceutical Buffers Revenue Growth Rate (2019-2030) & (US$ Million) Figure 44. Malaysia Biopharmaceutical Buffers Revenue Growth Rate (2019-2030) & (US$ Million) Figure 45. Philippines Biopharmaceutical Buffers Revenue Growth Rate (2019-2030) & (US$ Million) Figure 46. Latin America Biopharmaceutical Buffers Sales Market Share by Country (2019-2030) Figure 47. Latin America Biopharmaceutical Buffers Revenue Market Share by Country (2019-2030) Figure 48. Mexico Biopharmaceutical Buffers Revenue Growth Rate (2019-2030) & (US$ Million) Figure 49. Brazil Biopharmaceutical Buffers Revenue Growth Rate (2019-2030) & (US$ Million) Figure 50. Argentina Biopharmaceutical Buffers Revenue Growth Rate (2019-2030) & (US$ Million) Figure 51. Middle East & Africa Biopharmaceutical Buffers Sales Market Share by Country (2019-2030) Figure 52. Middle East & Africa Biopharmaceutical Buffers Revenue Market Share by Country (2019-2030) Figure 53. Turkey Biopharmaceutical Buffers Revenue Growth Rate (2019-2030) & (US$ Million) Figure 54. Saudi Arabia Biopharmaceutical Buffers Revenue Growth Rate (2019-2030) & (US$ Million) Figure 55. U.A.E Biopharmaceutical Buffers Revenue Growth Rate (2019-2030) & (US$ Million) Figure 56. Global Sales Market Share of Biopharmaceutical Buffers by Type (2019-2030) Figure 57. Global Revenue Market Share of Biopharmaceutical Buffers by Type (2019-2030) Figure 58. Global Biopharmaceutical Buffers Price (USD/MT) by Type (2019-2030) Figure 59. Global Sales Market Share of Biopharmaceutical Buffers by Application (2019-2030) Figure 60. Global Revenue Market Share of Biopharmaceutical Buffers by Application (2019-2030) Figure 61. Global Biopharmaceutical Buffers Price (USD/MT) by Application (2019-2030) Figure 62. Biopharmaceutical Buffers Value Chain Figure 63. Biopharmaceutical Buffers Production Process Figure 64. Channels of Distribution (Direct Vs Distribution) Figure 65. Distributors Profiles Figure 66. Bottom-up and Top-down Approaches for This Report Figure 67. Data Triangulation Figure 68. Key Executives Interviewed
GE Healthcare Thermo Fisher Scientific Danaher Corporation Sartorius StedimBiotech Merck Eppendorf Roche Nova Biomedicals Lonza Becton, and Dickinson and Company GEA
  • PRICE
  • $2900
    $5800
    $4350
    Buy Now

Our Clients